Skip to main content

Together we are beating cancer

Donate now

Research and trials

Showing 12 out of 1711 results
ASCO 2015
  • Science & Technology
  • Health & Medicine

ASCO 2015 round-up: immunotherapy continues to come of age

We take a look back at the excitement from - and add a few important caveats to - the research from this year's big US cancer conference. We take a look back at the excitement from - and add a few important caveats to - the research from this year's big US cancer conference.

by Alan Worsley | Analysis | 5 June 2015

5 June 2015

Dendritic cells

A new immunotherapy drug has shown continued promise fortreating various types of cancer in a series of trials presented at a US conference. A new immunotherapy drug has shown continued promise fortreating various types of cancer in a series of trials presented at a US conference.

by In collaboration with PA Media Group | News | 1 June 2015

1 June 2015

Street sign:

An in-depth discussion of a new study, which looked whether the role GPs play in diagnosing cancers early is linked to international differences in survival An in-depth discussion of a new study, which looked whether the role GPs play in diagnosing cancers early is linked to international differences in survival

by Brad Groves | Analysis | 28 May 2015

28 May 2015

For International Clinical Trials Day 2015 we look at how trials have changed - from the first recorded trial to today's modern cancer clinical trials. For International Clinical Trials Day 2015 we look at how trials have changed - from the first recorded trial to today's modern cancer clinical trials.

by Aine McCarthy | Analysis | 20 May 2015

20 May 2015

GP and patient

Our new report, Every Patient a Research Patient? looks at how well the NHS is performing at offering cancer patients the opportunity to take part in research. Our new report, Every Patient a Research Patient? looks at how well the NHS is performing at offering cancer patients the opportunity to take part in research.

by Dan Bridge | Analysis | 19 May 2015

19 May 2015

Riot police

We look at APOBECs - biological double-agents that start out as a friend to our cells but morph into a deadly enemy as cancers develop. We look at APOBECs - biological double-agents that start out as a friend to our cells but morph into a deadly enemy as cancers develop.

by Emma Smith | Analysis | 12 May 2015

12 May 2015

Liquid nitrogen science
  • Health & Medicine
  • Science & Technology

Pint of Science 2015: from cows to cancer clinical trials

Fancy hearing about the latest developments in cancer research? Well some of our scientists might be gathering in a venue near you to tell all. Fancy hearing about the latest developments in cancer research? Well some of our scientists might be gathering in a venue near you to tell all.

by Nick Peel | Analysis | 1 May 2015

1 May 2015

Telephone exchange

We go back to the 1980s, and the crucial discovery of a fundamental cancer gene by our researchers at The Institute of Cancer Research We go back to the 1980s, and the crucial discovery of a fundamental cancer gene by our researchers at The Institute of Cancer Research

by Buddhini Samarasinghe | Analysis | 29 April 2015

29 April 2015

This entry is part 22 of 30 in the series Our milestones
A man gardening

Dr Abi Fisher from our UCL Health Behaviour Research Centre blogs about her recent paper looking at physical activity rates in people with bowel cancer Dr Abi Fisher from our UCL Health Behaviour Research Centre blogs about her recent paper looking at physical activity rates in people with bowel cancer

by Dr Abi Fisher | Analysis | 29 April 2015

29 April 2015

We explore new research showing how particular genetic faults inside cancer cells can subvert a self-destruct switch and instead encourage cancer to spread. We explore new research showing how particular genetic faults inside cancer cells can subvert a self-destruct switch and instead encourage cancer to spread.

by Alan Worsley | Analysis | 16 April 2015

16 April 2015